Your trusted health, nutrition, and personalized lifestyle medicine resource

The Loss of Inflammatory ‘Breaking Signals’ in the Lung of Patients with Asthma

Bruce Levy, MD

 

In this interview, Bruce Levy, MD describes the loss of inflammatory ‘breaking signals’ in the lung of patients with asthma. Dr. Levy highlights how this defective resolution phenotype negatively impacts both adaptive and innate immune responses in individuals with asthma, leaving them more vulnerable to infection.

Bruce Levy, MD is the Chief of the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital, MA and Parker B. Francis Professor at Harvard Medical School

From the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2019 in St Petersburg, Florida

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

Sponsored by
© 2021 Metagenics Institute. All Rights Reserved
Stay up-to-date with COVID-19VIEW NOW
+